Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Fournier, S.
space
  arrow  Vincent, V.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Mycobacterium genavense and Cutaneous Disease in AIDS

right arrow Sandra Fournier; Gilles Pialoux; and Veronique Vincent

1 March 1998 | Volume 128 Issue 5 | Page 409


TO THE EDITOR:

A 49-year-old male homosexual patient with AIDS was hospitalized in April 1996 with chronic diarrhea. He had a history of pulmonary pneumocystosis and cryptococcal meningitis. Although blood and stool specimens revealed the presence of acid-fast bacilli, cultures (Bactec, radiometric method, Becton Dickinson Diagnostic Instrument Systems, Sparks, Maryland) remained negative. Treatment with clarithromycin (1 g/d) and ethambutol (1200 mg/d) was instituted under the hypothesis that the patient had Mycobacterium avium complex infection.

The patient was admitted again in June 1996 with abdominal pain, diarrhea, fever, and weight loss. Physical examination showed multiple swelling and painful cutaneous nodules on the abdomen and the tops of the limbs. Liver and spleen were normal. Body temperature was 39°C. Laboratory test results included a hemoglobin level of 6.4 g/dL, an alkaline phosphatase level of 1200 U/L, and a CD4 cell count of 6 cells/mm3. Computed tomography revealed abdominal lymph nodes. Duodenal biopsy showed histiocytic infiltration with acid-fast bacilli. Cutaneous biopsy showed granulomas with diffuse lymphocytic and histiocytic infiltration; acid-fast bacilli were seen on Ziehl-Neelsen stain. Rifampicin, 600 mg/d; isoniazide, 300 mg/d; and pyrazinamide, 1500 mg/d, were added to clarithromycin and ethambutol. Cutaneous lesions and abdominal pain resolved, but weakness and fever persisted. In October 1996, identification of the mycobacterial isolate by polymerase chain reaction restriction analysis of the hsp65 gene revealed M. genavense. No other mycobacterial strain was isolated. Treatment was changed to rifabutin, 450 mg/d; clarithromycin, 1 g/d; and ciprofloxacin, 1500 mg/d. The patient's condition deteriorated, with weight loss and recurrent anemia; the patient died in January 1997 without relapse of cutaneous lesions.

In 1990, Hirschel and colleagues isolated M. genavense for the first time in a patient with AIDS [1]. Since 1990, many cases have been reported. The more frequent signs and symptoms of infection with this organism are fever, weight loss, diarrhea with abdominal pain, hepatosplenomegaly, anemia, and pancytopenia [2]. No subcutaneous nodules have been reported with M. genavense infection. The nontuberculous mycobacteria responsible for cutaneous disease include M. marinum, M. fortuitum, M. chelonae, M. avium complex, and M. haemophilum [3]. In patients with AIDS, M. avium complex, M. fortuitum, and M. haemophilum are the most frequent agents of cutaneous infections [4]. Mycobacterium genavense must be added to this list.

The best treatment for M. genavense remains unknown, but clarithromycin is associated with clinical improvement and clearance of bacteremia [5]. Because of the low frequency of these infections, clinical trials are difficult to conduct to determine the best treatment. Diagnosis of M. genavense infection is difficult because of the fastidious growth requirements of the species. It should be suspected in patients with positive smears for acid-fast bacilli and no or poor growth of the organism. Frequency of M. genavense infection is probably underestimated because of difficulties with cultures. This organism may be the agent of cutaneous disease in patients with AIDS.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Hopital de l'Institut Pasteur; Paris, France
Institut Pasteur; Paris, France


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Hirschel B, Chang H, Mach N. Fatal infection with a novel unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med. 1990; 323:109-13.

2. Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, et al. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med. 1995; 155:400-4.

3. Street M, Umbert-Millet I, Roberts G, Su W. Nontuberculous mycobacterial infections of the skin. J Am Acad Dermatol. 1991; 24:208-15.

4. Dover J, Johnson R. Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol. 1991; 127:1549-58.

5. Bessesen M, Shlay J, Stone-Venohr B, Cohn D, Reves R. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993; 7:1357-61.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
D. E. Griffith, T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, et al.
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 367 - 416.
[Full Text] [PDF]


box Article
 arrow  Table of Contents                
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Fournier, S.
space
  arrow  Vincent, V.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online